Shoulder Arthroplasty in Transplant Recipients: Complications and Mortality


Given the increase in the incidence and survivability of those with solid organ transplantations in the United States, the purpose of this study was to identify inpatient, 30-day, and 90-day outcomes following primary shoulder arthroplasty in transplant recipients. The Healthcare Cost and Utilization Project State Inpatient Databases identified patients who underwent shoulder arthroplasty after solid organ transplantation between January 2007 and December 2013. International Classification of Diseases, Ninth Revision, codes were used to define the primary composite outcome of death or postoperative complication. Logistic models with frequency weights were used to compare propensity-matched groups. Patients undergoing primary shoulder arthroplasty following solid organ transplant are at elevated risk of inpatient and 30-day and 90-day postoperative complications (respiratory, hemorrhage) and have longer length of stays compared with nontransplant patients. Transplant patients did not have an increased risk of surgical site infection or mortality at any time point (Journal of Surgical Orthopaedic Advances 28(1):41–47, 2019)
Key words: complication, immunosuppression, infection, outcomes, shoulder arthroplasty, solid organ transplant

Patrick K. Strotman, MD; Anai Kothari, MD; Paul Kuo, MD, MBA, FACS; Dane H. Salazar, MD; and Nickolas Garbis, MD